Pain diagnosis
No standard PRP
Multidisciplinary
Women’s Health Clinic FAQ
What is the therapeutic approach when using the O-Shot for patients with localised neuroproliferative vestibulodynia?
Neuroproliferative vestibulodynia is a pain condition, so it should not be treated as a simple sensitivity or arousal problem.
Direct answer
Localised neuroproliferative vestibulodynia is a pain condition, not simply low sensitivity. The benchmark should make PRP a cautious specialist discussion rather than a standard therapeutic approach.
The useful answer explains why complex medical history can change suitability, while avoiding protocols, medicine-stopping advice or promises of response.
Educational only. Use this as general education before discussing your own medical history with a clinician. Results vary. Not a cure.
O-Shot suitability review
At a glance
These points frame the medical-history question before considering elective intimate PRP.
At a glance
Clinical summary
Pain first
Vestibulodynia needs diagnosis and pain-focused assessment before elective PRP is discussed.
Not routine
The O-Shot should not be framed as a standard treatment for neuroproliferative vestibulodynia.
Flare risk
Procedures around painful tissue can aggravate symptoms in some patients.
Team approach
Pelvic-floor, vulval-pain, psychosexual or specialist input may be needed.
Important safety note
Seek medical advice promptly for heavy or persistent bleeding, fever, offensive discharge, ulcers, severe pelvic or vulval pain, urinary retention, fainting, worsening swelling, suspected infection, systemic illness or unexplained genital lesions.
Vestibulodynia
Pelvic floor
Flare
Review
Detailed answer
Detailed answer
Pain with touch or sex is not the same as reduced sensation, low arousal or difficulty with orgasm.
Clinical context
Neuroproliferative vestibulodynia can involve nerve sensitivity, pelvic-floor guarding, inflammation, hormonal context and central pain processing.
Tissue
Safety
Evidence
What matters first
Pain with touch or sex is not the same as reduced sensation, low arousal or difficulty with orgasm.
Why review matters
Neuroproliferative vestibulodynia can involve nerve sensitivity, pelvic-floor guarding, inflammation, hormonal context and central pain processing.
Evidence boundary
PRP should be discussed cautiously, if at all, within a pain diagnosis and multidisciplinary plan.
Safety boundary
The safer page avoids presenting the O-Shot as a direct pain treatment or a shortcut to sexual comfort.
What this means in practice
A useful answer explains the clinical reason for caution without publishing protocols or implying suitability.
Medical history, medicines, tissue state and specialist input should be reviewed before elective intimate PRP.
Patient safety
Why this matters
Complex medical history can change blood draw safety, tissue resilience, infection risk, bleeding risk, pain interpretation and realistic expectations.
It avoids false reassurance
Autologous PRP does not automatically make treatment suitable for every complex history.
It protects sensitive tissue
Vulval, vaginal, neovaginal and periurethral tissue may be fragile, painful, scarred or affected by systemic illness.
It supports shared decisions
Some patients need oncology, renal, haematology, rheumatology, pelvic-floor or gender-surgery-aware input.
It keeps evidence honest
Intimate PRP protocols and patient groups vary, so outcomes should not be promised.
A careful treatment conversation
The question is not only whether PRP is biologically plausible, but whether it fits the patient's medical context.
That is why assessment, consent and follow-up are central to responsible intimate PRP care.
Considerations
What to consider
Consider the symptom target, diagnosis, medicines, bleeding history, infection risk, urinary symptoms, tissue fragility, surgery history, specialist follow-up and treatment goals.
Consultation priorities
The consultation reviews pain location, triggers, duration, pelvic-floor symptoms, skin conditions, infections, hormone context and previous treatments.
Medicines
Specialist
Follow-up
Assessment
The consultation reviews pain location, triggers, duration, pelvic-floor symptoms, skin conditions, infections, hormone context and previous treatments.
Safety review
The clinician considers whether vulval-pain, pelvic-floor physiotherapy, dermatology, psychosexual or pain-specialist input is needed.
Treatment fit
If PRP is discussed, consent should cover uncertainty, flare risk, discomfort and alternatives.
Review
Follow-up checks worsening pain, burning, swelling, urinary symptoms, bleeding or signs of infection.
Practical expectations
Response can be partial, delayed or absent, and published intimate PRP protocols are not uniform.
Prices, exact procedural details, treatment timing and aftercare should be confirmed with the clinic before booking.
Common concerns and myths
Common misconceptions
These myths can make complex suitability questions sound simpler than they are.
Myth: more sensation is always desirable
Reality: in pain conditions, increased sensitivity can be distressing.
Myth: PRP is a direct vestibulodynia treatment
Reality: evidence is limited and pain diagnosis comes first.
Myth: painful sex is solved by a sexual-function injection
Reality: pain can have skin, nerve, pelvic-floor, hormonal and psychological contributors.
Evidence and context
Mechanism helps explain why PRP is considered, but it does not replace diagnosis, specialist review or suitability checks.
Different outcomes
Comfort, arousal, lubrication, orgasm, urinary symptoms and pain are different outcomes and should not be blurred together.
Safety checklist
Safety checklist
Use these checks before assuming intimate PRP is suitable.
Is the medical history clear?
Clarify diagnosis, current stability, medicines, specialist follow-up and previous procedure reactions.
Has tissue context been reviewed?
Scarring, menopause-related change, infection symptoms, urinary issues, pain and active lesions can affect suitability.
Are red flags absent?
Pause and seek clinical review for new bleeding, fever, offensive discharge, ulcers, severe pain, urinary retention, fainting, spreading swelling, systemic illness or any concern about infection.
Is uncertainty documented?
Consent should explain limited evidence, variable response and possible discomfort, bruising or bleeding.
Reassuring signs
Proceeding is more reasonable when the condition is stable, red flags are absent and expectations are realistic.
No red flags
Review plan
Reasons to pause
Pause for unstable illness, new bleeding, infection symptoms, ulcers, severe pain, urinary retention, fainting, spreading swelling or uncertainty about medicine safety.
Infection
Unstable illness
When to escalate
When to seek medical help
Some symptoms around intimate PRP treatment need prompt assessment.
Use NHS 111 online
Bleeding or fainting
Heavy bleeding, persistent bleeding, spreading bruising or fainting should be assessed by a clinician.
Infection symptoms
Fever, offensive discharge, worsening burning, ulcers or pelvic pain may need swabs, urine testing or review.
Unexpected reaction
Worsening swelling, severe soreness, tissue colour change or new urinary difficulty should be reviewed.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Why pain must be separated from sensation
A treatment marketed around sensitivity may be inappropriate when the main problem is pain, burning or touch intolerance.Why multidisciplinary care matters
Vestibulodynia often needs a layered plan rather than one procedure. PRP should not replace proper pain assessment.Regulatory resources
Authoritative resources
These resources support evidence-aware, assessment-led discussion of intimate PRP and complex medical history.
O-Shot official questions
Competitor baseline for sexual-function and sensitivity claims.
O Shot and G Shot London competitor page
UK competitor source for patient expectation and claim gaps.
PRP injections for female sexual dysfunction and SUI systematic review
Clinical anchor for low-certainty intimate PRP evidence.
Next step
Book an intimate health consultation
A consultation can clarify whether symptoms fit GSM, sexual-function concerns, pelvic-floor pain, urinary symptoms or another cause, and whether PRP is suitable.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 72 curated sources. Additional reviewed material included peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate and low-relevance records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
